|
顯示項目 550631-550655 / 2346288 (共93852頁)
<< < 22021 22022 22023 22024 22025 22026 22027 22028 22029 22030 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2018-11 |
Liposomal irinotecan (nal-IRI) plus 5-FU/LV in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) progressing on gemcitabine-based treatment: Further subgroup analyses of the pivotal NAPOLI-1 study
|
Chen, LT;Mercade, TM;Lee, KH;Lakatos, G;Wang-Gillam, A;Mirakhur, B;de Jong, F |
| 國家衛生研究院 |
2020-01 |
Liposomal irinotecan + 5-FU/LV in metastatic pancreatic cancer: Subgroup analyses of patient, tumor, and previous treatment characteristics in the pivotal NAPOLI-1 trial
|
Macarulla Mercade, T;Chen, LT;Li, CP;Siveke, JT;Cunningham, D;Bodoky, G;Blanc, JF;Lee, KH;Dean, A;Belanger, B;Wang-Gillam, A |
| 國立成功大學 |
2020 |
Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial
|
MacArulla, Mercad� T.;Chen, L.-T.;Li, C.-P.;Siveke, J.T.;Cunningham, D.;Bodoky, G.;Blanc, J.-F.;Lee, K.-H.;Dean, A.;Belanger, Belanger B.;Wang-Gillam, A. |
| 國家衛生研究院 |
2019-03-04 |
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial
|
Macarulla, T;Blanc, JF;Wang-Gillam, A;Chen, LT;Siveke, JT;Mirakhur, B;Chen, J;de Jong, FA |
| 國立成功大學 |
2019 |
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial
|
Macarulla, T.;Blanc, J.-F.;Wang-Gillam, A.;Chen, L.-T.;Siveke, J.T.;Mirakhur, B.;Chen, J.;de, Jong F.A. |
| 國家衛生研究院 |
2019-12-01 |
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
|
Bang, YJ;Li, CP;Lee, KH;Chiu, CF;Park, JO;Shan, YS;Kim, JS;Chen, JS;Shim, HJ;Rau, KM;Choi, HJ;Oh, DY;Belanger, B;Chen, LT |
| 國立成功大學 |
2020 |
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
|
Bang, Y.-J.;Li, C.-P.;Lee, K.-H.;Chiu, Chiu C.-F.;Park, J.O.;Shan, Y.-S.;Kim, J.S.;Chen, J.-S.;Shim, H.-J.;Rau, K.-M.;Choi, H.J.;Oh, D.-Y.;Belanger, Belanger B.;Chen, L.-T. |
| 中山醫學大學 |
2021 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study
|
Chiu, TJ; Su, YY; Yang, SH; Li, CP; Bai, LY; Chiang, NJ; Chuang, SC; Shan, YS; Chan, DC; Chen, LT; Yen, CJ; Peng, CM; Chen, YY; Chen, JS; Chou, WC |
| 國家衛生研究院 |
2021-11-20 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
|
Chiu, TJ;Su, YY;Yang, SH;Li, CP;Bai, LY;Chiang, NJ;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Chen, YY;Chen, JS;Chou, WC |
| 國立成功大學 |
2021 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
|
Chiu, T.-J.;Su, Y.-Y.;Yang, S.-H.;Li, C.-P.;Bai, L.-Y.;Chiang, N.-J.;Chuang, S.-C.;Shan, Y.-S.;Chan, D.-C.;Chen, L.-T.;Yen, C.-J.;Peng, C.-M.;Chen, Y.-Y.;Chen, J.-S.;Chou, W.-C. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study
|
Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C. |
| 中山醫學大學 |
2016 |
Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme
|
YL, Lin; KF, Chang; XF, Huang; CL, Hung; SC, Chen; WR, Chao; KW, Liao; NM, Tsai |
| 國立交通大學 |
2019-04-03T06:35:34Z |
Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme
|
Lin, Yu-Ling; Chang, Kai-Fu; Huang, Xiao-Fan; Hung, Che-Lun; Chen, Shyh-Chang; Chao, Wan-Ru; Liao, Kuang-Wen; Tsai, Nu-Man |
| 臺大學術典藏 |
2021-07-07T02:12:42Z |
Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol
|
Huang S.-T.; YI-PING WANG; Chen Y.-H.; Lin C.-T.; Li W.-S.; Wu H.-C. |
| 臺大學術典藏 |
2022-03-04T06:10:52Z |
Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol
|
Huang S.-T.; Wang Y.-P.; Chen Y.-H.; CHIN-TARNG LIN; Li W.-S.; Wu H.-C. |
| 國家衛生研究院 |
2020-03-28 |
Liposomal TLR9 agonist combined with TLR2 agonist-fused antigen can modulate tumor microenvironment through dendritic cells
|
Shen, KY;Liu, HY;Yan, WL;Wu, CC;Lee, MH;Leng, CH;Liu, SJ |
| 臺大學術典藏 |
2019-07-23T01:51:04Z |
Liposomal vesicles-protein interaction: Influences of iron liposomes on emulsifying properties of whey protein
|
Li, Li;MIN-HSIUNG PAN;Zheng, Quanhui;Wei, Shudong;Ding, Baomiao;YANG-FANG CHEN;Chiou, Yi shiou;Li, Zhenshun;Hu, Jie;Yi, Xiangzhou;Duan, Shengzhou; Duan, Shengzhou; Yi, Xiangzhou; Hu, Jie; Li, Zhenshun; Chiou, Yi shiou; YANG-FANG CHEN; Ding, Baomiao; Wei, Shudong; Zheng, Quanhui; MIN-HSIUNG PAN; Li, Li |
| 臺大學術典藏 |
2021-06-22T02:01:33Z |
Liposomal vesicles-protein interaction: Influences of iron liposomes on emulsifying properties of whey protein
|
Yi, X.;Zheng, Q.;Pan, M.-H.;Chiou, Y.-S.;Li, Z.;Li, L.;Chen, Y.;Hu, J.;Duan, S.;Wei, S.;Ding, B.; Yi, X.; Zheng, Q.; Pan, M.-H.; Chiou, Y.-S.; Li, Z.; Li, L.; Chen, Y.; Hu, J.; Duan, S.; Wei, S.; Ding, B.; MIN-HSIUNG PAN |
| 中國醫藥大學 |
2005-12-15 |
Liposome as a Drug Carrier in Inhibiting Smooth Muscle Cell Proliferation
|
(Ching-Yun Chen); 陳語謙; 吳介信(副教授); 陳悅生 |
| 臺北醫學大學 |
2006 |
Liposome Composition for Delivery of a Therapeutic Agent to Eye
|
劉俊仁; Liu; J.J.Tseng; Y.L; Guo; L.Hong; K. |
| 中國醫藥大學 |
2007-03-18 |
LIPOSOME ENCAPSULATED MAGNOLOL AS A DRUG CARRIER IN INHIBITING SMOOTH MUSCLE CELL PROLIFERATION
|
(W.C Lee); (Y.J Chen); 陳語謙(Chen, Yu-Chian); (C.H Wu) |
| 臺北醫學大學 |
2008 |
Liposome encapsulation reduces cantharidin toxicity
|
劉得任; Liu DZ; Chang CC; Lin SY; Liang HJ; Hou WC; Liang YC |
| 臺北醫學大學 |
2008 |
Liposome encapsulation reduces cantharidin toxicity
|
黃偉展; Chang CC; Liu DZ; Lin SY; Liang HJ; Hou WC; Huang WJ; Chang CH; Ho FM; Liang YC |
| 元培科技大學 |
2008 |
Liposome encapsulation reduces cantharidin toxicity
|
Chun-Chao Chang; Der-Zen Liu; Shyr-Yi Lin; Hong-Jen Liang; Wen-Chi Hou; Wei-Jan Huang; Chih-Hsiang Chang; Feng-Ming Ho; and Yu-Chih Liang |
| 臺北醫學大學 |
2008 |
Liposome encapsulation reduces cantharidin toxicity.
|
梁有志; Chang CC; Liu DZ; Lin SY; Liang HJ; Hou WC; Huang WJ; Chang CH; Ho FM; Liang YC. |
顯示項目 550631-550655 / 2346288 (共93852頁)
<< < 22021 22022 22023 22024 22025 22026 22027 22028 22029 22030 > >>
每頁顯示[10|25|50]項目
|
